Spectral AI hits enrollment goal at burn centers for AI-powered assessment tech

A month after completing pediatric enrollment, Spectral AI has reached its adult enrollment goal at burn centres for a US pivotal study evaluating its AI wound diagnostics platform technology.

The US company said that data from the trial, which it claims is one of the largest domestic burn studies ever carried out, will be used to pursue a De Novo classification from the US Food and Drug Administration (FDA) for the system, called DeepView.